Company Filing History:
Years Active: 2018-2022
Title: Yandong Wen: Innovator in Neurodegenerative Disease Treatment
Introduction
Yandong Wen is a prominent inventor based in Weston, CT (US), known for his significant contributions to the field of pharmaceuticals. He holds three patents that focus on innovative treatments for neurodegenerative diseases, particularly those associated with hallucinations.
Latest Patents
Wen's latest patents include "Diaryl and arylheteroaryl urea derivatives as modulators of the 5-HT serotonin receptor useful for the prophylaxis and treatment of hallucinations associated with a neurodegenerative disease." This invention relates to specific pyrazole derivatives that modulate the activity of the 5-HT serotonin receptor, offering potential treatments for visual hallucinations linked to Lewy Body dementia. Another patent with a similar focus is also titled "Diaryl and arylheteroaryl urea derivatives as modulators of the 5-HT2A serotonin receptor useful for the prophylaxis and treatment of hallucinations associated with a neurodegenerative disease," further emphasizing his commitment to addressing these critical health issues.
Career Highlights
Yandong Wen is currently associated with Axovant Sciences GmbH, where he continues to develop innovative solutions for complex medical challenges. His work is characterized by a strong focus on the intersection of pharmacology and neurodegenerative disorders.
Collaborations
Wen collaborates with notable colleagues, including Lawrence Tim Friedhoff and Shankar Ramaswamy, enhancing the impact of his research through teamwork and shared expertise.
Conclusion
Yandong Wen's innovative work in the field of neurodegenerative disease treatment highlights his dedication to improving patient outcomes through scientific advancements. His patents represent significant strides in understanding and treating hallucinations associated with these conditions.